Neurxstem, Inc. — Department of Defense SBIR Phase I: AF212-CSO1
Neurxstem, Inc. — SBIR Phase I award from Department of Defense.
- Amount
- $49,717
- Agency
- Department of Defense · Air Force
- Program / Phase
- SBIR · Phase I
- Topic
- AF212-CSO1
- Solicitation
- X21.2
- NAICS
- —
- Place of performance
- OH
- Period
- 2021-11-05 → 2022-02-03
Description
Posttraumatic stress disorder (PTSD) and substance use disorder (SUD) often co-occur among Veterans seeking Veterans Affairs (VA) care. There is growing need for effective clinical treatment of co-occurring PTSD and SUD based on human data. A clear under